Skip to main content
Caplight Logo









metaLinear

metaLinear

Private
HarrogateHealthcare & Life Scienceshttps://metalinear.co.uk

Last Round

VC Round

Aug 20, 2019

Est. Valuation

$786,000

Total Funding Raised

$334,000

Company Overview

metaLinear operates in Healthcare & Life Sciences and is based in Harrogate. Its latest recorded funding round was a VC Round in August 2019.

metaLinear is a biotechnology company that provides a proprietary proteome engineering technology to uncover, characterize, and validate new targets for antibiotics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

metaLinear Comparables

Compare metaLinear with similar companies based on industry and business-model similarity.

metaLinear comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hybrigenics Services
77%
Avacta Group
66%
Bayer AG
62%
Book a demo to see all comparables

For institutional investors. Book with your work email.

metaLinear Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 20, 2019
VC RoundJul 30, 2018
SeedNov 8, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

metaLinear Investors

Notable investors and investment history

metaLinear investors
InvestorRounds
Pioneer GroupVC Round
Deepbridge CapitalVC Round
Catapult VenturesVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2018

    $188K round with Catapult Ventures and Pioneer Group.

Book a demo to see all signals

For institutional investors. Book with your work email.

metaLinear Filings

Explore SEC and related filing metadata, where available.

metaLinear filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about metaLinear's valuation, stock price, and market status.

Is metaLinear a public or private company?

metaLinear is a private company.

What is the current stock price of metaLinear?

metaLinear is a private company, so its shares have no public market price. Caplight tracks metaLinear's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is metaLinear worth (valuation)?

metaLinear's valuation is estimated at $786.0K based on funding round data.

Can I buy metaLinear stock?

metaLinear shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was metaLinear's last funding round?

metaLinear's most recent funding round was VC Round on August 20, 2019.

Who are the main investors in metaLinear?

Key investors in metaLinear include Catapult Ventures.

Will metaLinear IPO soon?

No public IPO plans have been announced for metaLinear.

How can I track metaLinear secondary market activity?

Caplight tracks bids, offers, and trades in metaLinear's shares on secondary markets.

Firmographic Details

HeadquartersHarrogate
Year Founded2016
Last FundingAug 20, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?